Park Avenue Securities’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Park Avenue Securities’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,574	Closed	-$919K	–	1793
2026 Q1	$919K	Buy	4,574 +395	+9%	+$81.7K	0.01%	850
2025 Q4	$863K	Sell	4,179 -112	-3%	-$22.4K	0.01%	869
2025 Q3	$769K	Buy	4,291 +220	+5%	+$37.5K	0.01%	988
2025 Q2	$657K	Sell	4,071 -30	-0.7%	-$4.78K	0.01%	942
2025 Q1	$698K	Buy	4,101 +183	+5%	+$31.8K	0.01%	735
2024 Q4	$651K	Buy	3,918 +365	+10%	+$62.4K	0.01%	956
2024 Q3	$611K	Buy	+3,553	New	+$588K	0.01%	899

Other funds holding FBT

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

BEI

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

HFM

Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return

AFA

Arlington Financial Advisors Santa Barbara, California $787M AUM 22.93% 1-Year Est. Return

SFI Advisors Montclair, New Jersey $116M AUM 37.12% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HFP

Holistic Financial Partners Indianapolis, Indiana $164M AUM 32.79% 1-Year Est. Return

Park Avenue Securities's FBT Position: Q2 2026 in Review

Park Avenue Securities sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 4,574 shares — an estimated $919K sold.

Park Avenue Securities first reported a position in FBT in Q3 2024 and held it in 7 quarters. The position peaked at $919K in Q1 2026. 109 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Park Avenue Securities reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
Park Avenue Securities sold 4,574 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $919K.
Park Avenue Securities first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2024 and held it in 7 quarters.
Park Avenue Securities's First Trust NYSE Arca Biotechnology Index Fund position peaked at $919K in Q1 2026.
109 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.